Bevacizumab beyond disease progression after first-line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non-small cell lung cancer (West Japan Oncology Group 5910L): An open-label, randomized, phase 2 trial
Takeda, Masayuki, Yamanaka, Takeharu, Seto, Takashi, Hayashi, Hidetoshi, Azuma, Koichi, Okada, Morihito, Sugawara, Shunichi, Daga, Haruko, Hirashima, Tomonori, Yonesaka, Kimio, Urata, Yoshiko, MurakamVolume:
122
Language:
english
Journal:
Cancer
DOI:
10.1002/cncr.29893
Date:
April, 2016
File:
PDF, 438 KB
english, 2016